Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Myocarditis 1 Myelodysplastic Syndromes 1 Lymphoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Biphenotypic, Acute 1 Arthritis 1

Interventions

Paclitaxel 20 Gemcitabine 16 Dexamethasone 16 Bevacizumab 16 Docetaxel 15 Oxaliplatin 14 Cyclophosphamide 13 Carboplatin 12 Capecitabine 12 Sorafenib 11 Fluorouracil 11 Leucovorin 10 Cisplatin 10 pembrolizumab 9 Prednisone 9 Pemetrexed 9 Epoetin Alfa 9 venetoclax 8 atezolizumab 8 Fentanyl 8 Drug Therapy 8 Doxorubicin 8 Rivaroxaban 7 Rituximab 7 Darbepoetin alfa 7 Anastrozole 7 Panitumumab 6 Ondansetron 6 Morphine 6 Irinotecan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Abatacept × Clear all

NCT05335928 2025-09-10

ATRIUM

Massachusetts General Hospital

Phase 3 Recruiting

Myocarditis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡